European Companies Search Engine

Quick Search Power Search
Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

6 EU fundings (€421,000): European Research Infrastructure on Highly Pathogenic Agents 2 … BdlYear 2015 EU Research and Innovation programme "Horizon"

Text

Inserm Transfert SA, Paris, France

20/10/2015 EU funding (€177,437): European Research Infrastructure on Highly Pathogenic Agents 2
01/02/2015 EU funding (€231,000): Ebola Virus: Modern Approaches for developing bedside Rapid Diagnostics – Sofia ref.: 115843
27/08/2015 EU funding (€279,625): Coordination Action in support of the sustainability and globalisation of the Joint Programming Initiative on Neurodegenerative Diseases
01/05/2015 EU funding (€389,491): Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone
01/05/2015 EU funding (€408,374): Application of omics-based strategies for improved diagnosis and treatment of endocrine hypertension
05/05/2015 EU funding (€421,000): Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Inserm Transfert SA, Paris, France.

Creative Commons License The visualizations for "Inserm Transfert SA - 6 EU fundings (€421,000): European Research Infrastructure on Highly Pathogenic Agents 2 …" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.
Close